Abstract:Background & aims: Liver fibrosis is characterized by significant accumulation of extracellular matrix (ECM) proteins, mainly fibrillar collagen-I, as a result of persistent liver injury. Cartilage oligomeric matrix protein (COMP) is largely found in the ECM of skeletal tissue. Increased COMP expression has been associated with fibrogenesis in systemic sclerosis, lung fibrosis, chronic pancreatitis, cirrhosis and hepatocellular carcinoma. We hypothesized that COMP could induce fibrillar collagen-I deposition and participate in matrix remodeling thus contributing to the pathophysiology of liver fibrosis. Methods: Thioacetamide (TAA) and carbon tetrachloride (CCl4) were used to induce liver fibrosis in wild-type (WT) and Comp-/- mice. In vitro experiments were performed with primary hepatic stellate cells (HSCs). Results: COMP expression was detected in livers from control WT mice and was upregulated in response to either TAA or CCl4-induced liver fibrosis. TAA-treated or CCl4-injected Comp-/- mice showed less liver injury, inflammation and fibrosis compared to their corresponding control WT mice. Challenge of HSCs with recombinant COMP (rCOMP) induced intra- plus extracellular collagen-I deposition and increased matrix metalloproteinases (MMPs) 2, 9 and 13, albeit similar expression of transforming growth factor beta (TGFβ) protein, in addition to Tgfβ, tumour necrosis factor alpha (Tnfα) and tissue inhibitor of metalloproteinases-1 (Timp1) mRNAs. We demonstrated that COMP binds collagen-I; yet, it does not prevent collagen-I cleavage by MMP1. Last, rCOMP induced collagen-I expression in HSCs via CD36 receptor signaling and activation of the MEK1/2-pERK1/2 pathway. Conclusion: These results suggest that COMP contributes to liver fibrosis by regulating collagen-I deposition. Lay summary: Cartilage oligomeric matrix protein (COMP) induces fibrillar collagen-I deposition via the CD36 receptor signaling and activation of the MEK1/2-pERK1/2 pathway, and participates in extracellular matrix remodeling contributing to the pathophysiology of liver fibrosis.

Incomplete B Cell Tolerance to Cartilage Oligomeric Matrix Protein in Mice.

Cartilage Oligomeric Matrix Protein Specific Antibodies Are Pathogenic

Antibodies to Cartilage Oligomeric Matrix Protein Are Pathogenic in Mice and May Be Clinically Relevant in Rheumatoid Arthritis

Cartilage Oligorneric Matrix Protein Induction Of Chronic Arthritis In Mice

Cartilage oligomeric matrix protein deficiency promotes early onset and the chronic development of collagen-induced arthritis

Cartilage Oligomeric Matrix Protein (Comp)-Induced Arthritis in Rats.

Cartilage Oligomeric Matrix Protein Induced Arthritis—A New Model for Rheumatoid Arthritis in the C57BL/6 Mouse

COMP does not directly modify the expression of genes involved in cartilage homeostasis in contrast to several other cartilage matrix proteins

Arthritis Induced with Minor Cartilage Proteins.

Effects of Cartilage Oligomeric Matrix Protein on Bone Morphogenetic Protein‐2‐induced Differentiation of Mesenchymal Stem Cells

Increased Serum Levels of Cartilage Oligomeric Matrix Protein in Chronic Erosive Arthritis in Rats

Cartilage oligomeric matrix protein participates in the pathogenesis of liver fibrosis

Intrinsic Tolerance in Autologous Collagen-Induced Arthritis is Generated by CD152-Dependent CD4+ Suppressor Cells

The Molecular Mechanism Study of COMP Involved in the Articular Cartilage Damage of Kashin-Beck Disease

Cartilage Oligomeric Matrix Protein is a Natural Inhibitor of Thrombin

Cartilage-binding Antibodies Initiate Joint Inflammation and Promote Chronic Erosive Arthritis

Two Major Genes Associated with Autoimmune Arthritis, Ncf1 and Fcgr2b, Additively Protect Mice by Strengthening T Cell Tolerance.

Cartilage Oligomeric Matrix Protein Improves in Vivo Cartilage Regeneration and Compression Modulus by Enhancing Matrix Assembly and Synthesis.

Systemic Versus Cartilage-Specific Expression Of A Type Ii Collagen-Specific T-Cell Epitope Determines The Level Of Tolerance And Susceptibility To Arthritis

ADAMTS-12 Associates with and Degrades Cartilage Oligomeric Matrix Protein

Pathogenic Autoreactive B Cells Are Not Negatively Selected Toward Matrix Protein Collagen II